BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 24, 2010
View Archived Issues
Promising phase I data on CAL-101 in hematological malignancies disclosed
Read More
Indian scientists claim new ketolides as antibacterial agents
Read More
Pfizer develops new glucocorticoid receptor agonists
Read More
Leo Pharma divulges new positive modulators of calcium-sensing receptor
Read More
New histamine H3 receptor antagonists presented by Evotec
Read More
Japan Tobacco patents new inhibitors of macrophage colony-stimulating factor 1 receptor
Read More
Sunesis begins phase III vosaroxin trial in acute myeloid leukemia
Read More
PTC Therapeutics completes enrollment of phase III Ataluren trial in cystic fibrosis
Read More
FDA grants orphan drug status to rFVIIIFc for hemophilia A treatment
Read More
VBL begins phase II study of VB-201 in patients with elevated hsCRP levels
Read More
AstraZeneca and Abbott discontinue development of Certriad for mixed dyslipidemia
Read More
Lentiviral vector-based vaccine VRX-1116 shows promise in HIV therapy
Read More
Lower risk of metabolic complications seen with darunavir vs. atazanavir plus ritonavir in HIV
Read More
TRPV4 antagonists hold promise for the treatment of bladder dysfunction
Read More
Combination of AZD-0530 and anastrozole shows promise in hormone receptor-positive breast cancer
Read More
Living Cell Technologies adds patients to Diabecell trial in New Zealand
Read More
FDA approves Amturnide, a triple-combination pill, to treat high blood pressure
Read More
Merck receives FDA approval for new indications for HPV vaccine Gardasil
Read More
FDA issues complete response letter for acetadote supplemental NDA
Read More
Gilead stops phase III trial of ambrisentan in IPF after interim analysis
Read More
Amylin and Lilly submit NDA for Byetta as an add-on therapy to basal insulin
Read More
Medicago provides phase II update on avian influenza vaccine
Read More
Intercell begins phase I trial of IC-84 against Clostridium difficile infections
Read More
Threshold reports phase I data for TH-302 in patients with advanced leukemia
Read More
Pfizer submits supplemental NDAs to FDA and EMA for Prevnar 13
Read More